Articles

A new label-free biosensor platform generates kinetics and affinity data in a single run.

Not only does aging affect people differently, but it also affects their organs at varying rates too.

Anna Blakney, an RNA bioengineer and TikTok science communicator, studies how self-amplifying RNA improves RNA vaccines and therapeutics.

Researchers discovered that combining two FDA-approved drugs prevents ovulation over the entire fertile window, leading to a potential new option for on-demand birth control.

Scientists and clinicians discussed their solutions for overcoming the challenge of getting past the blood-brain barrier in DDN’s first seminar.

Online programs help scientists expand their skills for an advanced career in drug development.

It’s human nature to compare one’s success to others, but thinking that the grass is greener on the other side can be detrimental to one’s health. Recognizing strategies as equal but unique ways to tackle a common problem is a healthier perspective.

A once fringe theory that viral and bacterial infections trigger the neuroinflammation and cognitive decline associated with Alzheimer’s disease is gaining traction. If it proves true, available antimicrobials could be a long sought-after treatment for this neurodegenerative disease.

Researchers face more obstacles studying the lung microbiome than the gut microbiome. One big hurdle is collecting lung samples. In a new study, researchers used an invasive technique to collect fluid from children’s lungs and discovered how the lung’s microbial makeup affects stem cell transplant outcomes.

Improved chemistry may make RNA editing therapies more feasible in humans.